Herbal Monograph
Grapeseed Extract
Vitis vinifera L.
Vitaceae
Potent vascular antioxidant from grape seeds, rich in OPCs for vein health and capillary protection
Overview
Plant Description
Vitis vinifera is a vigorous, deciduous, woody climbing vine (liana) that grows 12-15 meters (40-50 feet) or more in length, attaching to supports by means of forked tendrils positioned opposite the leaves. The bark is shredding and flaky on older wood, while young shoots are green and smooth. Leaves are alternate, palmately lobed with 3-5 pointed lobes, 5-20 cm across, with coarsely serrate margins and a cordate (heart-shaped) base. Leaf surfaces are often pubescent beneath. Small, fragrant, greenish-yellow hermaphroditic flowers are borne in dense panicles (thyrses) in May-June. The fruit is a berry (the grape), borne in clusters (bunches), varying widely in size, color (green, red, purple, black), and flavor depending on the cultivar. Seeds are small, pyriform (pear-shaped), 4-6 mm long, with a hard, woody outer coat and a starchy endosperm. Each grape typically contains 1-4 seeds. The medicinal product -- grape seed extract -- is derived from the small, hard seeds that are a byproduct of the wine and juice industry. These seeds are rich in polyphenolic compounds, particularly oligomeric proanthocyanidins (OPCs), which are concentrated in the seed coat and endosperm.
Habitat
Wild Vitis vinifera subsp. sylvestris is found in humid forests, riparian woodlands, and forest margins in warm temperate to subtropical climates. The wild form is dioecious and occurs naturally in deciduous and mixed forests, often climbing into the canopy of supporting trees. It favors deep, well-drained, moderately fertile soils, and tolerates a range of soil types from sandy to clay loams, preferring neutral to slightly alkaline pH. The cultivated grape (subsp. vinifera) is one of the most extensively planted fruit crops on Earth, grown in vineyards across all continents except Antarctica. It thrives in Mediterranean climates with warm, dry summers and mild, wet winters, but has been adapted to a wide range of growing conditions through millennia of selective breeding.
Distribution
Vitis vinifera is native to the Mediterranean region, central Europe, and southwestern Asia, with the wild progenitor (V. vinifera subsp. sylvestris) ranging from the Iberian Peninsula and North Africa east through the Caucasus, Anatolia, and Iran to Central Asia. Domestication occurred approximately 6000-8000 years ago, likely in the South Caucasus region (modern Georgia, Armenia) or the northern Zagros Mountains of Iran. Today, cultivated grapes are grown globally in temperate and subtropical regions. Major wine and grape-producing countries include France, Italy, Spain, the United States (California), Australia, Chile, Argentina, South Africa, Germany, and China. Grape seed extract is produced worldwide, with major manufacturing in France, Italy, the United States, and China, utilizing seeds from the wine industry as raw material.
Parts Used
Seed extract (Vitis viniferae semen extractum)
Preferred: Standardized extract powder (80-95% OPCs) in capsule or tablet form; liquid extract
The dried, mature seeds of Vitis vinifera are extracted to produce a standardized extract rich in oligomeric proanthocyanidins (OPCs). This is the primary medicinal preparation and the form used in virtually all clinical trials and pharmacological studies. Standardized grape seed extracts typically contain 80-95% oligomeric proanthocyanidins (OPCs) by weight, with the remainder comprising monomeric flavanols (catechin, epicatechin), gallic acid, and other phenolic compounds. The OPC content is the key quality marker and the basis for therapeutic dosing. Whole, unextracted seeds have limited bioavailability due to the hard seed coat; extraction and standardization are essential for therapeutic use.
Seed oil (Oleum Vitis viniferae)
Preferred: Cold-pressed oil for topical or culinary use
Cold-pressed oil from grape seeds is rich in polyunsaturated fatty acids, particularly linoleic acid (omega-6, approximately 60-75% of total fatty acids), with smaller amounts of oleic acid, palmitic acid, and stearic acid. Also contains vitamin E (tocopherols) and trace polyphenols. Used primarily as a culinary oil and in cosmetic/topical formulations. The fatty acid and tocopherol content provides emollient and mild antioxidant properties when applied topically. Grape seed oil does NOT contain significant OPC concentrations and should not be confused with or substituted for standardized grape seed extract for therapeutic purposes.
Leaf (Vitis viniferae folium)
Preferred: Standardized red vine leaf extract (AS 195) in tablet form
Red grape vine leaves (harvested in autumn when red coloration indicates high anthocyanin content) are the subject of a separate EMA (European Medicines Agency) monograph and are used in European phytotherapy for chronic venous insufficiency. The leaf extract (marketed as Antistax/AS 195) contains flavonoids including quercetin-3-O-glucuronide and isoquercetin, anthocyanins, and some proanthocyanidins. While sharing some overlapping indications with seed extract (venous insufficiency, leg edema), the chemical profile and clinical evidence base are distinct. The leaf monograph is separate from the seed extract monograph in regulatory terms.
Key Constituents
Oligomeric proanthocyanidins (OPCs)
Oligomeric proanthocyanidins are the principal active constituents of grape seed extract and the basis for all therapeutic standardization. OPCs are responsible for the venotonic (strengthening vein wall integrity), antioxidant (free radical scavenging 20-50 times more potent than vitamins C and E in some in vitro assays), anti-inflammatory (NF-kB inhibition, COX-2 suppression), anti-edema (capillary-stabilizing, reduced vascular permeability), and cardioprotective actions. The mechanism of vascular protection is primarily through OPC binding to collagen and elastin in vessel walls, cross-linking and stabilizing these structural proteins while inhibiting their enzymatic degradation by matrix metalloproteinases (MMPs), collagenase, elastase, and hyaluronidase. This results in reduced capillary fragility, decreased vascular permeability, and improved venous tone. OPC content (typically standardized to 80-95%) is the primary quality marker for therapeutic grape seed extracts.
Monomeric flavan-3-ols (catechins)
Monomeric catechins contribute to the overall antioxidant, anti-inflammatory, and cardiovascular-protective properties of grape seed extract. They are highly bioavailable and detectable in plasma within 30-60 minutes of oral ingestion. While individually less potent than the oligomeric forms for vascular protection, catechins provide complementary free radical scavenging (particularly against superoxide and hydroxyl radicals) and contribute to the endothelium-protective effects through nitric oxide pathway enhancement.
Phenolic acids
Phenolic acids contribute to the overall antioxidant capacity of grape seed extract and serve as bioavailable metabolites of the larger proanthocyanidin compounds. Gallic acid in particular is a significant contributor to in vivo antioxidant effects and may account for some of the anti-inflammatory activity observed clinically.
Stilbenes
Resveratrol is present only in trace quantities in grape seed extract and does not significantly contribute to its therapeutic effects. The well-publicized health effects of resveratrol (from grape skins and red wine) should not be conflated with the OPC-based activity of grape seed extract. They are pharmacologically distinct preparations from different parts of the same plant.
Fatty acids (in seed oil)
The fatty acid constituents are relevant to grape seed oil (used as a culinary and cosmetic oil) rather than the standardized polyphenolic extract used therapeutically. Grape seed oil's high linoleic acid content provides a light, non-comedogenic emollient for topical use. The fatty acid profile is not the basis for the venotonic and antioxidant indications of grape seed extract.
Herbal Actions
Prevents or slows oxidative damage to cells
Grape seed OPCs are among the most potent natural antioxidants identified. In vitro studies demonstrate free radical scavenging activity 20-50 times greater than vitamin C and vitamin E on a molar basis against specific reactive oxygen species (superoxide anion, hydroxyl radical, peroxyl radical). OPCs scavenge free radicals directly, chelate pro-oxidant transition metal ions (iron, copper), inhibit lipid peroxidation, protect LDL cholesterol from oxidative modification, and enhance the activity of endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase). Clinical studies demonstrate increased plasma total antioxidant capacity and reduced markers of oxidative stress (malondialdehyde, 8-isoprostane) following grape seed extract supplementation. The antioxidant activity underpins many of the downstream therapeutic effects, including cardioprotection, vasoprotection, and anti-inflammatory activity.
[2, 3, 10]Tightens and tones tissue, reduces secretions
OPCs and proanthocyanidins are by definition condensed tannins, and as such possess significant astringent properties. The astringent action of grape seed OPCs is central to their venotonic and vasoprotective mechanism: OPCs bind to and cross-link collagen and elastin proteins in vascular and connective tissue, tightening and toning the tissue matrix. This tannin-protein binding stabilizes blood vessel walls, reduces capillary permeability and fragility, and decreases pathological fluid exudation (edema). The astringent action also inhibits enzymatic degradation of connective tissue proteins by collagenase, elastase, and hyaluronidase. In Western herbal energetics, astringency is the defining taste quality of grape seed, reflecting the tannin content and the tissue-tightening, fluid-reducing mechanism of action.
[1, 2, 12]Reduces inflammation
Grape seed OPCs demonstrate clinically relevant anti-inflammatory activity through multiple mechanisms: inhibition of NF-kB transcription factor activation (reducing production of pro-inflammatory cytokines TNF-alpha, IL-1beta, IL-6), inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzyme activity, suppression of histamine release from mast cells, and downregulation of adhesion molecule expression on endothelial cells (reducing leukocyte recruitment to sites of inflammation). In vivo studies demonstrate suppression of carrageenan-induced paw edema, cotton pellet granuloma, and UV-induced skin inflammation. Clinical anti-inflammatory effects are observed in the reduction of edema in chronic venous insufficiency and post-surgical swelling.
[3, 7, 10]Strengthens and tones the heart muscle
Grape seed extract supports cardiovascular function through several complementary mechanisms: enhancement of endothelial nitric oxide (NO) production via epicatechin and OPCs, promoting vasodilation and healthy blood flow; inhibition of LDL oxidation, a critical step in atherosclerotic plaque formation; modest reduction of systolic and diastolic blood pressure demonstrated in meta-analysis (Zhang et al. 2016: weighted mean reduction of 6.1 mmHg systolic, 2.8 mmHg diastolic); improvement of endothelial function as measured by flow-mediated dilation; and mild antiplatelet activity. These effects are considered cardioprotective and supportive rather than directly cardiotropic.
[3, 5, 8]Lowers blood pressure
Meta-analysis of 16 randomized controlled trials (Zhang et al. 2016, 810 subjects) demonstrated statistically significant reductions in both systolic blood pressure (WMD -6.08 mmHg, P<0.001) and diastolic blood pressure (WMD -2.80 mmHg, P<0.01) with grape seed extract supplementation. Subgroup analysis found stronger effects in younger populations (<50 years), obese individuals, and those with metabolic disorders. Sano et al. (2007) demonstrated significant blood pressure reduction in Japanese subjects with mild hypertension (prehypertension) using a low-dose grape seed OPC extract. The hypotensive mechanism involves enhancement of endothelial nitric oxide bioavailability and ACE inhibitory activity of proanthocyanidin fractions.
[5, 6, 8]Promotes wound healing
Grape seed OPCs promote wound healing through several mechanisms: stabilization and cross-linking of collagen fibers (enhancing wound tensile strength), stimulation of vascular endothelial growth factor (VEGF) expression (promoting angiogenesis in the wound bed), antioxidant protection of cells in the wound environment from oxidative damage, and anti-inflammatory modulation that supports resolution of wound inflammation. Preclinical studies demonstrate accelerated wound closure, increased collagen deposition, and improved wound tensile strength with topical and oral grape seed extract. A clinical trial using grape seed extract ointment on cesarean section wounds showed significant improvement in wound approximation.
[3, 10]Protects the liver from damage
Animal studies demonstrate hepatoprotective effects of grape seed proanthocyanidins against various hepatotoxic agents (carbon tetrachloride, acetaminophen, alcohol). Mechanisms include: enhancement of hepatic antioxidant enzyme systems (SOD, GPx, catalase), inhibition of lipid peroxidation in hepatic membranes, and suppression of pro-fibrotic stellate cell activation. Clinical evidence for hepatoprotection in humans is limited and largely preliminary, placing this as a mild rather than primary action.
[3, 10]Kills or inhibits the growth of microorganisms
In vitro studies demonstrate antimicrobial activity of grape seed proanthocyanidins against certain Gram-positive bacteria (Staphylococcus aureus, Streptococcus mutans), some Gram-negative species, and Candida albicans. Mechanism involves disruption of bacterial cell membrane integrity by tannin binding to surface proteins. The clinical relevance of this antimicrobial activity at typical oral supplement doses is uncertain. Topical application of grape seed extract has shown promise in dental health (anti-caries, anti-gingivitis) due to local antimicrobial and anti-inflammatory effects.
[3, 10]Therapeutic Indications
Cardiovascular System
Chronic venous insufficiency (CVI) and varicose veins
The best-documented indication for grape seed extract. Chronic venous insufficiency involves impaired venous return from the lower extremities, resulting in leg heaviness, pain, swelling (edema), nocturnal leg cramps, skin changes, and varicose veins. Multiple RCTs and a Cochrane review of phlebotonics (Martinez-Zapata et al. 2016, updated 2021) have evaluated grape seed OPCs for CVI. Grape seed extract at 100-300 mg/day of standardized OPC extract significantly reduces leg edema (measured by leg volume, ankle circumference), improves subjective symptoms (heaviness, pain, fatigue, tingling, cramping), and enhances venous tone. The mechanism involves OPC stabilization of vascular collagen and elastin, reduced capillary permeability, anti-inflammatory effects on venous walls, and enhancement of venous smooth muscle tone. This indication has regulatory support in France where OPC-containing preparations have marketing authorization for venous insufficiency.
[2, 7, 9, 12]Peripheral edema and leg swelling
Grape seed OPCs reduce peripheral edema through their capillary-stabilizing and anti-inflammatory actions. In CVI trials, significant reductions in leg circumference and volume are consistently demonstrated. A study in healthy women found that 400 mg of grape seed proanthocyanidin extract reduced leg swelling by 70% during prolonged sitting. Post-operative edema following breast cancer surgery showed significant reduction with 600 mg/day grape seed extract over 6 months. The anti-edema effect is mediated by: reduced capillary permeability (tightening of endothelial junctions), inhibition of fluid transudation, and anti-inflammatory suppression of mediators that increase vascular permeability.
[3, 7, 9]Hypertension (mild, adjunctive management)
A meta-analysis of 16 RCTs (Zhang et al. 2016, n=810) demonstrated significant blood pressure reduction with grape seed extract: systolic BP reduced by a weighted mean of 6.08 mmHg and diastolic BP by 2.80 mmHg. Effects were more pronounced in younger individuals (<50 years), obese subjects, and those with metabolic disorders. Sano et al. (2007) demonstrated that grape seed OPCs at 200 mg/day significantly reduced blood pressure in Japanese subjects with pre-hypertension over 8 weeks. Sivaprakasapillai et al. (2009) confirmed blood pressure reduction and improved endothelial function with grape seed extract in subjects with metabolic syndrome. Mechanism involves enhanced endothelial nitric oxide production and modest ACE inhibitory activity.
[5, 6, 8]Atherosclerosis risk reduction (LDL oxidation inhibition)
Grape seed OPCs potently inhibit oxidative modification of LDL cholesterol in vitro and ex vivo, a critical early step in atherogenesis. Clinical studies demonstrate reduced plasma malondialdehyde (a lipid peroxidation marker) and improved flow-mediated dilation (an indicator of endothelial function) with grape seed extract supplementation. However, no long-term clinical trials have demonstrated reduction in atherosclerotic cardiovascular events (myocardial infarction, stroke) with grape seed extract. The evidence supports a role as an antioxidant and endothelial-protective agent that may contribute to cardiovascular risk reduction as part of a comprehensive approach, but hard endpoint outcome data are lacking.
[3, 5, 10]Skin / Integumentary
Capillary fragility and easy bruising
OPCs strengthen capillary walls by binding to and stabilizing the collagen and elastin matrix of the vessel wall, inhibiting enzymatic degradation by collagenase, elastase, and hyaluronidase. This reduces capillary fragility and permeability, decreasing susceptibility to bruising and petechiae. This indication was among the earliest studied for OPCs, with Masquelier's pioneering work documenting improved capillary resistance following OPC supplementation. Clinical studies using the capillary resistance test (negative pressure suction cup) have demonstrated significant improvement in capillary strength with grape seed OPC extract.
[2, 3, 7]Skin aging and UV photoprotection
Grape seed OPCs protect dermal collagen and elastin from oxidative and enzymatic degradation, potentially slowing the visible signs of skin aging (loss of elasticity, wrinkling). UV-protective effects are demonstrated in animal models: oral grape seed extract reduced UV-induced skin erythema, lipid peroxidation, and sunburn cell formation. OPCs inhibit matrix metalloproteinases (MMPs) that degrade dermal collagen in response to UV radiation and chronological aging. Human clinical evidence for anti-aging effects is limited and largely preliminary (small studies, short duration), though the mechanistic rationale is strong.
[3, 10]Wound healing support
Preclinical evidence shows grape seed OPCs accelerate wound healing through enhanced collagen synthesis, VEGF-mediated angiogenesis, and antioxidant protection of wound tissue. A double-blind RCT of grape seed extract ointment (2.5% and 5%) on cesarean section wounds demonstrated significantly improved wound approximation compared to placebo at days 6 and 14. Oral supplementation studies in animal models show increased wound tensile strength and faster closure times. Clinical evidence in humans remains limited.
[3, 10]Musculoskeletal System
Inflammatory joint conditions and sports-related edema
The anti-inflammatory and anti-edema properties of grape seed OPCs extend to musculoskeletal inflammation and swelling. A clinical study found that subjects who took grape seed extract after a sports injury experienced less swelling than those taking placebo. The COX-2 and 5-LOX inhibitory activity, combined with the capillary-stabilizing effects that reduce inflammatory fluid exudation, provide a mechanistic rationale for use in inflammatory joint and soft tissue conditions. However, large-scale clinical trials in arthritis or sports medicine are lacking.
[3, 10]Endocrine System
Metabolic syndrome (adjunctive support)
Sivaprakasapillai et al. (2009) demonstrated that grape seed extract improved blood pressure, endothelial function, and oxidative stress markers in subjects with metabolic syndrome. The combined antioxidant, anti-inflammatory, blood pressure-lowering, and endothelium-protective effects suggest potential benefit as adjunctive support in metabolic syndrome. Some evidence suggests modest effects on glycemic control and insulin sensitivity, though this requires larger confirmatory trials.
[3, 5, 8]Nervous System
Cognitive protection and neuroprotection (age-related cognitive decline)
Preclinical studies demonstrate that grape seed proanthocyanidins cross the blood-brain barrier and exert neuroprotective effects through antioxidant, anti-inflammatory, and anti-amyloid mechanisms. In vitro and animal studies show inhibition of amyloid-beta aggregation and toxicity, protection against oxidative neuronal damage, and improvement in memory and learning tasks in aged animal models. A clinical study in older adults reported improved cognitive function scores after grape seed extract supplementation. However, large-scale, long-duration human trials for prevention or slowing of age-related cognitive decline or dementia are not yet available.
[3, 10]Immune System
Allergic conditions (histamine modulation)
Grape seed proanthocyanidins inhibit histamine release from mast cells in vitro and suppress the production of pro-allergic cytokines (IL-4, IL-5, IL-13). Animal models of allergic airway inflammation show reduced bronchial hyperresponsiveness and eosinophilic infiltration with grape seed extract treatment. Jack Masquelier's early research noted the anti-histaminic effects of OPCs. Clinical evidence in human allergic conditions (rhinitis, asthma, urticaria) is limited to small studies and case reports, and this remains a preliminary indication.
[2, 3]Hepatobiliary System
Hepatoprotection (oxidative and toxic liver injury)
Animal studies demonstrate that grape seed proanthocyanidins protect against hepatotoxicity induced by carbon tetrachloride, acetaminophen, dimethylnitrosamine, and ethanol. Mechanisms include: enhancement of hepatic antioxidant defenses (glutathione, SOD, catalase), inhibition of lipid peroxidation, suppression of hepatic stellate cell activation (anti-fibrotic), and reduction of pro-inflammatory cytokines in the liver. Human clinical evidence is limited; no large-scale RCTs have evaluated grape seed extract specifically for liver disease in human populations.
[3, 10]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
hot/excitation, damp/relaxation, damp/stagnation
In Western herbal energetics, grape seed extract is classified as cool and slightly drying. The dominant taste quality is astringent, reflecting the high tannin (proanthocyanidin) content, with a secondary bitter note from phenolic acids and some tannin fractions. The cooling, astringent quality indicates grape seed's affinity for hot, inflamed conditions with tissue laxity and excessive fluid exudation -- precisely the presentation seen in chronic venous insufficiency with edema, hot swollen legs, capillary fragility, and inflammatory vascular conditions. The slightly drying quality addresses damp/relaxation tissue states (boggy, edematous tissues with poor venous tone and fluid accumulation) and damp/stagnation states (sluggish venous return, pooling of blood and fluid in the lower extremities). The cooling nature makes grape seed extract appropriate for inflammatory conditions with heat signs (redness, warmth, swelling) while contraindicating it energetically for cold, depleted, dry constitutions where a warming, moistening approach would be more appropriate. CAVEAT: Herbal energetics are interpretive frameworks within Western herbalism; they are not standardized across all practitioners and should be integrated with clinical and pharmacological evidence.
Traditional Uses
Mediterranean folk medicine and European viticulture tradition
- Grape seeds and grape pomace used in traditional Mediterranean folk medicine as astringent remedies for diarrhea, dysentery, and hemorrhage
- Unripe grape juice (verjuice) used as a sour condiment with reputed digestive and astringent properties
- Grape leaves applied as poultices for inflammation, minor wounds, and varicose veins
- Grape vine sap ('tears of the vine' collected from pruned canes in spring) used as eye drops for inflammation and as a folk remedy for skin conditions
- Wine and wine vinegar used medicinally for wound cleansing, digestive complaints, and as a vehicle for herbal preparations
"The medicinal use of the grape vine (Vitis vinifera) dates to Greek antiquity. Dioscorides (De Materia Medica, ca. 70 CE) described the astringent properties of unripe grape juice, grape leaves, and grape vine tendrils, recommending them for bleeding, dysentery, and inflammatory conditions. Galen similarly employed grape-derived preparations as astringent and cooling remedies. The seeds specifically, while consumed incidentally, were not isolated as a distinct medicinal preparation until the 20th century."
French phytotherapy (Masquelier's OPC research tradition, 1947 onwards)
- Standardized grape seed OPC extracts used for chronic venous insufficiency and varicose veins
- Treatment of capillary fragility, easy bruising, and hemorrhoidal complaints
- Anti-edema treatment for lymphedema and post-operative swelling
- Antioxidant supplementation for cardiovascular protection
- Visual health support, particularly for night vision and diabetic retinopathy
"In 1947, Professor Jack Masquelier at the University of Bordeaux isolated oligomeric proanthocyanidins (OPCs) first from peanut skins during his doctoral thesis, then later identified them in high concentrations in grape seeds and French maritime pine bark. Masquelier demonstrated that OPCs strengthened capillary walls and reduced vascular permeability, leading to the development of standardized OPC extracts that received French pharmaceutical marketing authorization. Masquelier's OPC extracts were registered as pharmaceutical products in France for the treatment of capillary fragility and venous insufficiency. The French phytotherapy tradition represents the bridge between traditional grape-based folk remedies and modern evidence-based phytomedicine, with grape seed OPC extracts remaining registered pharmaceutical products in France today."
Traditional Indian medicine (Ayurveda and Unani)
- Grape (Draksha) used as a nutritive tonic, laxative, and blood purifier
- Grapes and grape products used in Aasavs (alcohol-based medicinal tonics)
- Treatment of cough, respiratory catarrh, and hoarseness
- Used for subacute cases of enlarged liver and spleen
- Grape preparations used as cooling, soothing agents for burning sensations and thirst
"In Ayurvedic medicine, the grape (Draksha, Vitis vinifera) is classified as madhura (sweet), sheeta (cooling), and guru (heavy). It is used as a rasayana (rejuvenating tonic) and is included in various formulations for respiratory, digestive, and hepatic conditions. The Unani medical tradition similarly employs grape preparations as temperament-balancing cooling agents. Note that these traditional uses refer to the whole grape fruit and derived preparations rather than isolated seed extract, which is a modern development."
Modern Western herbalism and evidence-based phytotherapy
- Standardized grape seed OPC extract for chronic venous insufficiency, heavy legs, and varicose veins
- Antioxidant support for cardiovascular health and prevention of atherosclerosis
- Adjunctive blood pressure management in mild hypertension and metabolic syndrome
- Capillary strengthening for easy bruising, spider veins, and retinal microvascular health
- Anti-inflammatory and anti-edema support post-surgery and for sports injuries
- Skin health and photoprotection (both oral and topical preparations)
"Modern Western herbalism has adopted grape seed extract primarily on the basis of its robust clinical evidence for venous insufficiency and its exceptional antioxidant profile. Herbalists such as David Hoffmann and Kerry Bone include grape seed OPCs in cardiovascular and venous support protocols. The transition from traditional grape/vine folk remedies to standardized seed extract is one of the clearest examples in phytotherapy of translating traditional knowledge into evidence-based practice."
Modern Research
Blood pressure reduction: meta-analysis of randomized controlled trials
Meta-analysis of 16 randomized controlled trials (810 total subjects) evaluating the effect of grape seed extract supplementation on systolic and diastolic blood pressure.
Findings: Grape seed extract significantly reduced systolic blood pressure (weighted mean difference -6.08 mmHg, 95% CI -9.67 to -2.49, P<0.001) and diastolic blood pressure (WMD -2.80 mmHg, 95% CI -4.86 to -0.74, P<0.01) across all studies. Subgroup analysis revealed stronger effects in subjects younger than 50 years, in obese individuals, and in patients with metabolic disorders. Doses ranged from 100 to 2000 mg/day across trials, with most studies using 150-600 mg/day. The blood pressure reduction is clinically meaningful and comparable to first-line lifestyle interventions.
Limitations: Heterogeneity in grape seed extract preparations, doses, and study populations across the 16 trials. Most individual trials had relatively small sample sizes and short durations (4-16 weeks). Publication bias could not be entirely excluded. Long-term blood pressure effects beyond 16 weeks are not well characterized.
[5]
Phlebotonics for chronic venous insufficiency (Cochrane systematic review)
Cochrane systematic review evaluating the efficacy and safety of oral phlebotonic drugs (including grape seed extract, horse chestnut, Daflon/micronized purified flavonoid fraction, and others) for chronic venous insufficiency. Multiple trials included grape seed proanthocyanidin extracts among the phlebotonics assessed.
Findings: Phlebotonics including grape seed-derived OPCs showed significant benefit in reducing leg edema, improving symptoms of heaviness, pain, and discomfort, and improving overall quality of life in CVI patients compared to placebo. Grape seed extract-specific subgroup data showed significant reduction in leg volume and ankle circumference. Adverse events were mild and infrequent across phlebotonic studies. The review concluded that phlebotonics are effective for reducing edema and symptoms in CVI, though evidence for individual agents varied in quality.
Limitations: Heterogeneous phlebotonic preparations grouped together in some analyses. Quality of individual trials varied from low to moderate. Most trials were short-term (4-12 weeks). Limited data on long-term outcomes, disease progression, or hard vascular endpoints. Grape seed extract was evaluated in fewer trials than some other phlebotonics (e.g., horse chestnut, Daflon).
[9]
Cardiovascular risk markers: meta-analysis of grape seed extract RCTs
Systematic review and meta-analysis of randomized controlled trials evaluating the effect of grape seed extract on cardiovascular risk markers including lipid profiles, blood pressure, C-reactive protein, and oxidative stress markers.
Findings: Grape seed extract supplementation significantly reduced systolic blood pressure and heart rate. A significant reduction in LDL cholesterol and triglycerides was observed in some subgroups. C-reactive protein and malondialdehyde (oxidative stress marker) were reduced with grape seed extract compared to placebo. Flow-mediated dilation (a measure of endothelial function) was improved. The overall profile suggests a favorable effect on multiple cardiovascular risk factors simultaneously.
Limitations: Variable extract standardization and dosing across trials. Relatively short study durations (most 4-12 weeks). Small individual trial sample sizes. No cardiovascular outcome data (MI, stroke, cardiovascular death). The clinical significance of changes in surrogate markers for long-term cardiovascular risk reduction remains uncertain.
Blood pressure reduction in pre-hypertensive Japanese subjects
Randomized, double-blind, placebo-controlled trial of low-dose grape seed OPC extract (200 mg/day) in Japanese subjects with pre-hypertension (systolic 120-139 mmHg or diastolic 80-89 mmHg) over 8 weeks.
Findings: Grape seed extract at 200 mg/day significantly reduced both systolic and diastolic blood pressure compared to placebo over 8 weeks in subjects with pre-hypertension. Mean reductions were approximately 5-6 mmHg systolic and 3-4 mmHg diastolic. No significant adverse effects were reported. The study is notable for demonstrating efficacy at a relatively low dose and in a pre-hypertensive rather than hypertensive population, suggesting potential for early cardiovascular risk intervention.
Limitations: Small sample size. Single-center Japanese population; results may not generalize to other ethnicities. Short duration (8 weeks). Specific OPC extract preparation tested; results may vary with different extracts. Pre-hypertensive subjects only; larger trials in established hypertension needed.
[6]
Grape seed extract in chronic venous insufficiency: Italian clinical studies
Series of clinical trials by Belcaro and colleagues evaluating standardized grape seed proanthocyanidin extract (Leucoselect, 100-300 mg/day) in patients with chronic venous insufficiency and related microcirculatory disorders.
Findings: Grape seed extract significantly reduced leg edema (measured by ankle circumference and leg volume), improved subjective symptoms (heaviness, pain, fatigue, paresthesia, nocturnal cramps), and enhanced microcirculatory parameters (capillary filtration rate, transcutaneous oxygen measurements) compared to placebo and compared to no treatment. Effects were dose-dependent, with 300 mg/day showing greater benefit than 100 mg/day. Improvements were apparent within 2-4 weeks of treatment. Combined with compression stockings, grape seed extract provided additional benefit over stockings alone.
Limitations: Individual studies had moderate sample sizes (40-100 participants). Most were conducted in Italian populations. Some studies were open-label rather than fully blinded. Specific commercial extract (Leucoselect) used; results may vary with other preparations. Long-term outcomes beyond 8-12 weeks not evaluated.
[7]
Blood pressure and endothelial function in metabolic syndrome
Randomized, double-blind, placebo-controlled trial of grape seed extract (150 and 300 mg/day) in subjects with metabolic syndrome over 4 weeks, assessing blood pressure, endothelial function, and oxidative stress.
Findings: Both doses of grape seed extract significantly reduced systolic and diastolic blood pressure compared to placebo. Oxidized LDL levels were significantly reduced. Improvements in flow-mediated dilation (endothelial function marker) were observed. Plasma malondialdehyde (oxidative stress) decreased. No significant adverse effects were noted. The results suggest that grape seed extract addresses multiple components of metabolic syndrome risk simultaneously.
Limitations: Small sample size. Short duration (4 weeks). Specific extract preparation. Single-center study. Surrogate endpoints only; no hard cardiovascular outcome data. Effects beyond 4 weeks not assessed.
[8]
Comprehensive review of grape seed proanthocyanidin pharmacology and clinical evidence
Systematic review of the pharmacological properties and clinical evidence for grape seed proanthocyanidin extracts, covering antioxidant, cardiovascular, anti-cancer, neuroprotective, and anti-inflammatory activities.
Findings: Comprehensive review confirmed: (1) OPCs are potent free radical scavengers exceeding vitamins C and E in vitro; (2) clinical evidence supports use in chronic venous insufficiency and edema; (3) blood pressure-lowering effects are documented in multiple RCTs; (4) cardioprotective effects include LDL oxidation inhibition and endothelial function improvement; (5) preclinical evidence supports neuroprotective, hepatoprotective, and anti-cancer properties, though clinical evidence for these indications remains preliminary; (6) excellent safety profile with no significant adverse events in clinical trials. The review identified grape seed extract as one of the best-characterized and safest botanical supplements available.
Limitations: Narrative synthesis of heterogeneous evidence. Quality of individual studies varied. Preclinical findings may not translate to clinical outcomes. Limited data on long-term use beyond 12-16 weeks in most indications.
[3]
Free radical scavenging and cytoprotective effects of grape seed proanthocyanidins
In vitro and in vivo investigation of the antioxidant and cytoprotective properties of a novel IH636 grape seed proanthocyanidin extract (GSPE), evaluating free radical scavenging, inhibition of lipid peroxidation, and protection against oxidative tissue damage.
Findings: GSPE demonstrated superior free radical scavenging activity compared to vitamin C, vitamin E, and beta-carotene in multiple in vitro assays. In vivo, GSPE provided significant protection against acetaminophen-induced hepatotoxicity, amiodarone-induced pulmonary toxicity, doxorubicin-induced cardiotoxicity, and dimethylnitrosamine-induced spleen and brain damage in animal models. The cytoprotective effects were attributed to both direct antioxidant action and enhancement of endogenous antioxidant enzyme systems. GSPE also accelerated wound healing in animal models, with increased VEGF expression, enhanced collagen deposition, and improved wound tensile strength.
Limitations: Primarily in vitro and animal studies. The specific IH636 GSPE preparation may not represent all commercial grape seed extracts. Animal model results require confirmation in human clinical trials. Doses used in animal studies may not directly translate to human therapeutic doses.
[10]
Masquelier's grape seed extract: historical development and characterization
Comprehensive review tracing the historical development of Masquelier's grape seed OPC extract from the original 1947 discovery through modern characterization, covering chemical composition, standardization methods, pharmacology, and clinical evidence.
Findings: Detailed the history of OPC discovery by Jack Masquelier in 1947, originally from peanut skin and later from grape seeds and pine bark. Documented the chemical characterization of OPCs as oligomers of flavan-3-ol units (primarily epicatechin) with a degree of polymerization of 2-5. Confirmed the venotonic mechanism: OPCs bind to collagen and elastin in vessel walls, inhibiting enzymatic degradation by collagenase, elastase, and hyaluronidase, thereby strengthening vascular integrity and reducing permeability. Reviewed the registration of OPC preparations as pharmaceutical products in France for venous insufficiency and capillary fragility. Summarized clinical evidence for CVI, edema, capillary strengthening, and antioxidant effects.
Limitations: Narrative rather than systematic review. Some potential for author bias given the historical connection to Masquelier's research program. Does not comprehensively cover all post-2015 clinical evidence.
[2]
Effect of grape seed proanthocyanidin extract on diabetic retinopathy
Clinical trial evaluating the effect of grape seed proanthocyanidin extract on hard exudates and retinal parameters in patients with non-proliferative diabetic retinopathy, compared to calcium dobesilate and placebo.
Findings: In a study of 124 participants with non-proliferative diabetic retinopathy, grape seed extract was more effective than both placebo and calcium dobesilate (a standard treatment) at reducing hard exudates (lipid and protein deposits that leak from damaged retinal blood vessels). The reduction in hard exudates suggests improved retinal microvascular integrity consistent with the capillary-stabilizing mechanism of OPCs. However, there was no significant difference in the progression of diabetic retinopathy as measured by retinal grading scales over the study duration.
Limitations: Moderate sample size (n=124). Hard exudates are a surrogate marker; progression of retinopathy is the more clinically meaningful endpoint and was not significantly affected. Relatively short study duration. Single-center study. The clinical meaningfulness of hard exudate reduction without impact on disease progression is debatable.
[11]
Preparations & Dosage
Standardized Extract
Strength: Standardized to 80-95% oligomeric proanthocyanidins (OPCs). Drug-extract ratio varies by manufacturer but is typically 30-50:1 (i.e., 30-50 kg of seeds yields 1 kg of standardized extract).
Commercially prepared standardized grape seed extract, typically produced by aqueous-ethanol or ethyl acetate extraction of dried, crushed grape seeds, followed by purification and spray-drying to yield a powder standardized to a minimum OPC content (commonly 80-95% oligomeric proanthocyanidins by weight). The standardization is based on the vanillin-HCl assay, the Porter method, or HPLC quantification of procyanidins. Products should specify the OPC percentage and the extraction/standardization method. Major commercial standardized extracts include Leucoselect (Indena), Masquelier's OPCs, ActiVin, and MegaNatural. Clinical trial evidence is primarily based on extracts standardized to 80-95% OPCs.
150-300 mg of standardized extract (80-95% OPCs) daily, typically divided into 1-2 doses. For chronic venous insufficiency: 150-300 mg/day. For blood pressure support: 150-300 mg/day. For general antioxidant support: 100-200 mg/day. Higher doses up to 600 mg/day have been used in some clinical trials.
Once or twice daily, taken with meals to optimize absorption and reduce any risk of gastrointestinal discomfort
For CVI and edema: minimum 4-8 weeks for meaningful clinical effect; may be used long-term. For blood pressure: continuous use recommended; effects diminish upon discontinuation. For general antioxidant support: may be used as a long-term daily supplement.
Not well-established for children. Grape seed extract has not been extensively studied in pediatric populations. Adolescents: half adult dose may be considered under practitioner guidance.
Standardized extract is the recommended and most evidence-based preparation for all therapeutic indications. The high degree of standardization (80-95% OPCs) ensures consistent dosing and reproducible clinical effects. This is the form used in virtually all published clinical trials. Products should be verified by third-party testing for OPC content, as quality varies among commercial brands. Bioavailability of OPCs from standardized extracts is moderate; monomeric catechins and dimeric procyanidins are well absorbed, while larger oligomers may undergo colonic metabolism to smaller phenolic acids.
Capsule / Powder
Strength: Typically 50-200 mg standardized extract per capsule, standardized to 80-95% OPCs
Standardized grape seed extract powder (80-95% OPCs) encapsulated in vegetarian or gelatin capsules. Each capsule typically contains 50-200 mg of standardized extract. This is the most common commercial form of grape seed extract and the most convenient for daily supplementation. Select products that clearly state OPC percentage and are third-party tested for potency and purity.
150-300 mg of standardized extract daily (e.g., 1-3 capsules of 100 mg, or 1-2 capsules of 150 mg). For therapeutic use in CVI or hypertension: 200-300 mg/day. For general antioxidant support: 100-150 mg/day.
Once or twice daily with meals
May be used long-term. For CVI: minimum 8-12 weeks for full benefit assessment.
Not established. Not recommended for routine use in children without practitioner guidance.
Capsule form provides the most convenient and accurately dosed delivery method for standardized grape seed extract. Unlike many herbal preparations where crude powder capsules are an option, grape seed extract is virtually always used in standardized form due to the low bioavailability of OPCs from unextracted whole seeds (the hard seed coat severely limits dissolution and absorption). Products labeled simply as 'grape seed powder' (unextracted) should be avoided for therapeutic purposes.
Tincture
Strength: 1:5, 45-60% ethanol
Hydroalcoholic extract of dried grape seeds. Use finely ground dried seeds at a 1:5 ratio in 45-60% ethanol. Macerate for 4-6 weeks with daily agitation. Press and filter. The dark reddish-brown liquid has a strongly astringent taste. Note that a tincture preparation does not achieve the same degree of OPC concentration as a commercially standardized extract and is less commonly used than capsules of standardized extract. However, liquid preparations may offer faster absorption and are useful in formula blending.
2-4 mL (40-80 drops) three times daily
Two to three times daily, diluted in a small amount of water
May be used long-term as part of a herbal formula
Not recommended for children due to alcohol content and lack of pediatric data
Tincture preparation of grape seed is less common than standardized extract capsules in modern practice, as the standardized powder provides a more precisely dosed and concentrated OPC delivery. However, tinctures are useful in traditional herbal practice for blending into multi-herb formulas (e.g., combined with horse chestnut and butcher's broom for venous insufficiency protocols). The strongly astringent taste reflects the high tannin content and can be diluted or masked in juice.
Salve / Ointment
Strength: 2.5-5% grape seed extract in ointment base
For topical application: grape seed extract powder (2.5-5%) incorporated into a base ointment or cream. Combine standardized grape seed extract powder with a suitable carrier (e.g., shea butter, coconut oil, beeswax base). Heat the carrier to melting, stir in the grape seed extract powder thoroughly, and allow to cool and solidify. Alternatively, grape seed oil can be used as the carrier oil base with added extract powder for a combined preparation. Apply to affected areas 1-2 times daily.
Apply a thin layer of 2.5-5% grape seed extract ointment to affected skin 1-2 times daily
Once to twice daily
Use until healing is achieved or symptoms resolve. For wound healing: 2-4 weeks.
Topical use not well studied in children. Likely safe for external application at adult concentrations.
Topical grape seed extract preparations have shown benefit in wound healing studies, particularly for cesarean section wound approximation. The combination of OPC collagen-stabilizing properties, antioxidant protection, and anti-inflammatory effects makes topical application rational for wound care, skin inflammation, and vascular skin conditions (spider veins, bruising). Grape seed oil (cold-pressed) is also widely used in cosmetic and dermatological formulations as an emollient carrier with its own mild antioxidant properties from tocopherol content.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Individuals with confirmed allergy to grapes or grape products should avoid grape seed extract. Allergic reactions to grape seed extract are very rare but have been reported (urticaria, angioedema). Cross-reactivity with other fruits in the Vitaceae family is theoretically possible.
Grape seed proanthocyanidins demonstrate antiplatelet activity in vitro and in vivo, inhibiting both ADP-induced and collagen-induced platelet aggregation. As a precautionary measure, grape seed extract should be discontinued at least 2 weeks prior to elective surgery to minimize any theoretical risk of increased bleeding. This is consistent with general guidance for supplements with antiplatelet properties, though no case reports of significant surgical bleeding attributed specifically to grape seed extract have been published.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Warfarin, heparin, enoxaparin, and other anticoagulants (Anticoagulants) | moderate | Grape seed proanthocyanidins inhibit platelet aggregation in vitro through inhibition of thromboxane A2 formation and ADP-induced platelet activation. Concurrent use with pharmacological anticoagulants could theoretically increase bleeding risk through additive anticoagulant/antiplatelet mechanisms. |
| Aspirin, clopidogrel, prasugrel, and other antiplatelet agents (Antiplatelet agents) | moderate | Additive inhibition of platelet aggregation. Grape seed OPCs inhibit platelet function through mechanisms distinct from but complementary to pharmaceutical antiplatelet drugs, potentially increasing bleeding risk. |
| Antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, diuretics, beta-blockers) (Antihypertensives) | minor | Additive blood pressure-lowering effect. Grape seed extract reduces blood pressure through enhanced endothelial nitric oxide production and mild ACE inhibitory activity, potentially augmenting the effects of antihypertensive medications. |
| Metformin, sulfonylureas, insulin, and other antidiabetic agents (Hypoglycemic agents) | theoretical | Grape seed proanthocyanidins may modestly lower blood glucose levels through inhibition of alpha-glucosidase and alpha-amylase, enhancement of insulin sensitivity, and improvement of glucose uptake. Additive hypoglycemia is theoretically possible. |
| CYP450 substrates (broad theoretical interaction) (Drugs metabolized by cytochrome P450 enzymes) | theoretical | In vitro studies suggest grape seed proanthocyanidins may modulate certain CYP450 enzyme activities, including inhibition of CYP3A4, CYP2C9, and CYP2D6 at high concentrations. Whether clinically relevant enzyme inhibition occurs at typical oral supplement doses is uncertain. |
Pregnancy & Lactation
Pregnancy
insufficient data
Lactation
insufficient data
There is insufficient clinical safety data on the use of concentrated grape seed extract supplements during pregnancy and lactation. No controlled studies in pregnant or breastfeeding women have been conducted. Grape seeds consumed as part of the normal diet (eating grapes) are considered safe during pregnancy. However, concentrated OPC extracts at therapeutic doses (150-600 mg/day) have not been studied for safety in pregnancy. The antiplatelet activity raises a theoretical concern for increased bleeding risk during delivery. As a precautionary measure, therapeutic doses of grape seed extract supplements should be avoided during pregnancy and breastfeeding unless specifically recommended by a qualified healthcare provider. Dietary consumption of grapes and grape products in normal food amounts is not a concern.
Adverse Effects
References
Monograph Sources
- [1] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) . ISBN: 978-0892817498
- [2] Aron PM, Kennedy JA. Masquelier's grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits. Nutr J (2017) ; 16 : 5 . DOI: 10.1186/s12937-016-0218-1 . PMID: 28103873
- [3] Kar P, Laight D, Rooprai HK, Shaw KM, Cummings M. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med (2009) ; 26 : 526-531 . DOI: 10.1111/j.1464-5491.2009.02727.x . PMID: 19646193
- [4] National Center for Complementary and Integrative Health (NCCIH). Grape Seed Extract: Usefulness and Safety. NCCIH, National Institutes of Health, Bethesda, MD (2024)
Clinical Studies
- [5] Zhang H, Liu S, Li L, Liu S, Liu S, Mi J, Tian G. The impact of grape seed extract treatment on blood pressure changes: A meta-analysis of 16 randomized controlled trials. Medicine (Baltimore) (2016) ; 95 : e4247 . DOI: 10.1097/MD.0000000000004247 . PMID: 27537554
- [6] Sano A, Uchida R, Saito M, Shioya N, Komori Y, Tho Y, Hashizume N. Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol (Tokyo) (2007) ; 53 : 174-182 . DOI: 10.3177/jnsv.53.174 . PMID: 17615006
- [7] Belcaro G, Cesarone MR, Errichi BM, Ledda A, Di Renzo A, Stuard S, Dugall M, Pellegrini L, Rohdewald P, Ippolito E, Ricci A, Cacchio M, Ruffini I, Fano F, Hosoi M. Venous insufficiency treatment with Leucoselect grape seed extract. Panminerva Med (2004) ; 46 : 61-72
- [8] Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F, Kappagoda T. Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism (2009) ; 58 : 1743-1746 . DOI: 10.1016/j.metabol.2009.05.030 . PMID: 19608210
- [9] Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, Baird Z, Cosp XB, Wollina U. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev (2016) ; 4 : CD003229 . DOI: 10.1002/14651858.CD003229.pub3 . PMID: 27048768
- [10] Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology (2000) ; 148 : 187-197 . DOI: 10.1016/s0300-483x(00)00210-9 . PMID: 10962138
- [11] Saito M, Kimoto M, Tsuchiya K. Effect of grape seed proanthocyanidin extract on hard exudates in patients with non-proliferative diabetic retinopathy. Int J Ophthalmol (2019) ; 12 : 836-842 . DOI: 10.18240/ijo.2019.05.21 . PMID: 31124931
Traditional Texts
- [12] European Medicines Agency (EMA), Committee on Herbal Medicinal Products (HMPC). Assessment report on Vitis vinifera L., folium. EMA/HMPC/464684/2009 (2010)
Pharmacopeias & Reviews
- [13] United States Pharmacopeia. Grape Seeds Oligomeric Proanthocyanidins. USP-NF, Dietary Supplement Standards, Rockville, MD (2020)
- [14] European Pharmacopoeia Commission. Vitis viniferae semen (Grape Seed) and Vitis viniferae folium (Red Vine Leaf). European Pharmacopoeia, Council of Europe, Strasbourg (2020)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.